Cargando…

Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors modulate incretin hormones and exert anti-diabetic effects in type 2 diabetes mellitus. Treatment with angiotensin II type 1 receptor blockers (ARB) is a proven successful intervention for hypertension with type 2 diabetes. The present study inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyagawa, Katsutoshi, Kondo, Tatsuya, Goto, Rieko, Matsuyama, Rina, Ono, Kaoru, Kitano, Sayaka, Kawasaki, Shuji, Igata, Motoyuki, Kawashima, Junji, Matsumura, Takeshi, Motoshima, Hiroyuki, Araki, Eiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176757/ https://www.ncbi.nlm.nih.gov/pubmed/24188631 http://dx.doi.org/10.1186/1475-2840-12-160

Ejemplares similares

Mild Electrical Stimulation with Heat Shock Reduces Visceral Adiposity and Improves Metabolic Abnormalities in Subjects with Metabolic Syndrome or Type 2 Diabetes: Randomized Crossover Trials
por: Kondo, Tatsuya, et al.
Publicado: (2014)

Activation of heat shock response to treat obese subjects with type 2 diabetes: a prospective, frequency-escalating, randomized, open-label, triple-arm trial
por: Kondo, Tatsuya, et al.
Publicado: (2016)

Mineralocorticoid Receptor May Regulate Glucose Homeostasis through the Induction of Interleukin-6 and Glucagon-Like peptide-1 in Pancreatic Islets
por: Goto, Rieko, et al.
Publicado: (2019)

Identification of microRNA that represses IRS-1 expression in liver
por: Ono, Kaoru, et al.
Publicado: (2018)

The Amount of Residual Incretin Regulates the Pancreatic β-cell Function and Glucose Homeostasis
por: Kondo, Tatsuya, et al.
Publicado: (2021)

The Role of Heat Shock Response in Insulin Resistance and Diabetes
por: Kondo, Tatsuya, et al.
Publicado: (2014)

Activation of heat shock response improves biomarkers of NAFLD in patients with metabolic diseases
por: Kondo, Tatsuya, et al.
Publicado: (2021)

Acetate alters expression of genes involved in beige adipogenesis in 3T3-L1 cells and obese KK-Ay mice
por: Hanatani, Satoko, et al.
Publicado: (2016)

Impacts of the 2016 Kumamoto Earthquake on glycemic control in patients with diabetes
por: Kondo, Tatsuya, et al.
Publicado: (2018)

Rapid and dramatic glucose‐lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma
por: Igata, Motoyuki, et al.
Publicado: (2020)

Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma
por: Igata, Motoyuki, et al.
Publicado: (2016)

The clinical course and pathophysiological investigation of adolescent gestational diabetes insipidus: a case report
por: Kondo, Tatsuya, et al.
Publicado: (2018)

Hyperthermia With Mild Electrical Stimulation Protects Pancreatic β-Cells From Cell Stresses and Apoptosis
por: Kondo, Tatsuya, et al.
Publicado: (2012)

Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination
por: Shimoda, Seiya, et al.
Publicado: (2013)

Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis
por: Kume, Shinji, et al.
Publicado: (2012)

A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study)
por: Shimoda, Seiya, et al.
Publicado: (2016)

New perspectives on insulin therapy
por: Araki, Eiichi, et al.
Publicado: (2020)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

Surfing the Vildagliptin Tsunami
por: Balachandran, Karthik
Publicado: (2020)

Low glucose induces mitochondrial reactive oxygen species via fatty acid oxidation in bovine aortic endothelial cells
por: Kajihara, Nobuhiro, et al.
Publicado: (2017)

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
por: Das, Sambit, et al.
Publicado: (2021)

Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report
por: Saishouji, Fumi, et al.
Publicado: (2022)

Effect of Vildagliptin on Hepatic Steatosis
por: Macauley, Mavin, et al.
Publicado: (2015)

Ezetimibe improves glucose metabolism by ameliorating hepatic function in Japanese patients with type 2 diabetes
por: Ichimori, Shinji, et al.
Publicado: (2011)

Effects of vildagliptin as add-on treatment in patients with type 2 diabetes mellitus: insights from long-term clinical studies in Japan
por: Odawara, Masato, et al.
Publicado: (2016)

A rare case showing subacute thyroiditis-like symptoms with amyloid goiter after anti-tumor necrosis factor therapy
por: Kawashima, Junji, et al.
Publicado: (2015)

Single administration of vildagliptin attenuates postprandial hypertriglyceridemia and endothelial dysfunction in normoglycemic individuals
por: NOGUCHI, KAORU, et al.
Publicado: (2015)

Mild acute pancreatitis with vildagliptin use
por: Saraogi, Ravikant, et al.
Publicado: (2012)

Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis
por: Wiciński, Michał, et al.
Publicado: (2020)

Angiotensin II Receptor–Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats
por: Seki, Takunori, et al.
Publicado: (2017)

Hyperglycemia Induces Cellular Hypoxia through Production of Mitochondrial ROS Followed by Suppression of Aquaporin-1
por: Sada, Kiminori, et al.
Publicado: (2016)

Vildagliptin is Effective for Glycemic Control in Diabetic Patients Undergoing either Hemodialysis or Peritoneal Dialysis
por: Ito, Hiroyuki, et al.
Publicado: (2013)

Drug fever and acute inflammation from hypercytokinemia triggered by dipeptidyl peptidase‐4 inhibitor vildagliptin
por: Anno, Takatoshi, et al.
Publicado: (2018)

A case of vildagliptin-induced interstitial pneumonia
por: Kuse, Naoyuki, et al.
Publicado: (2016)

Physicochemical Properties and Methods of Analysis of Vildagliptin (Review)
por: Polyakova, E. B., et al.
Publicado: (2022)

Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
por: Kudo‐Fujimaki, Kyoko, et al.
Publicado: (2013)

Bioequivalence Studies of New Generic Formulations of Vildagliptin and Fixed-Drug Combination of Vildagliptin and Metformin Versus Respective Originator Products in Healthy Volunteers
por: Schnaars, Yvonne, et al.
Publicado: (2022)

The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes
por: Moon, Jun Sung, et al.
Publicado: (2013)

Vildagliptin/metformin: Lactic acidosis and hypoglycaemia: case report
Publicado: (2022)

Association between circulating leukocyte subtype counts and carotid intima-media thickness in Japanese subjects with type 2 diabetes
por: Matsumura, Takeshi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9ndl94rubkf3kjh43pb1q5v1kk